COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody?

被引：0
|
作者：
Autore, Francesco [1 ]
Visentin, Andrea [2 ]
Deodato, Marina [3 ]
Vitale, Candida [4 ]
Galli, Eugenio [1 ]
Fresa, Alberto [1 ]
Fazzi, Rita [5 ]
Sanna, Alessandro [6 ]
Olivieri, Jacopo [7 ]
Scortechini, Ilaria [8 ]
Principe, Maria Ilaria Del [9 ]
Sportoletti, Paolo [1 ,10 ,11 ]
Innocenti, Idanna [1 ]
Coscia, Marta [4 ]
Tedeschi, Alessandra [3 ]
Trentin, Livio [2 ]
Candoni, Anna [12 ]
Busca, Alessandro [4 ]
Pagano, Livio [1 ,2 ,13 ]
Laurenti, Luca [1 ,13 ]
机构：
[1] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Lab & Infettivolog, Rome, Italy
[2] Univ Padua, Dept Med, Hematol Unit, Padua, Italy
[3] ASST Grande Osped Metropolitano Niguarda, Div Hematol, Milan, Italy
[4] AOU Citta Salute Sci Torino, Div Hematol, Turin, Italy
[5] Azienda Osped Univ Pisana, UO Ematol, Pisa, Italy
[6] Azienda Osped Univ Careggi, Dept Oncol, Hematol Unit, Florence, Italy
[7] Azienda Sanit Univ Friuli Cent, Clin Ematol Udine, Udine, Italy
[8] Azienda osped Univ Marche, Clin Ematol, Ancona, Italy
[9] Univ Roma Tor Vergata, Dipartimento Biomed Prevenz, Rome, Italy
[10] Univ Perugia, Inst Hematol, Dept Med & Surg, AO Santa Maria della Misericordia Perugia, Perugia, Italy
[11] Univ Perugia, Ctr Hemato Oncol Res CREO, AO Santa Maria della Misericordia Perugia, Perugia, Italy
[12] Univ Modena & Reggio Emilia, Dept Med & Surg Sci, Sect Haematol, Modena, Italy
[13] Univ Cattolica Sacro Cuore, Dipartimento Diagnost Immagini Radioterapia Oncolo, Dipartimento Diagnostica Immagini, Rome, Italy
来源：
BLOOD ADVANCES | 2025年 / 9卷 / 01期
关键词：
D O I：
10.1182/bloodadvances.2024013792
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：162 / 165
页数：4
相关论文
共 50 条
  • [21] Place of monoclonal antibodies (anti-CD52, anti-CD20) in chronic lymphocytic leukemia
    Divine, Marine
    HEMATOLOGIE, 2006, 12 : 35 - 38
  • [22] Orphan-drug status granted to new anti-CD20 monoclonal antibody for chronic lymphocytic leukemia
    不详
    IMMUNOTHERAPY, 2010, 2 (01) : 7 - 7
  • [23] Orphan-drug status granted to new anti-CD20 monoclonal antibody for chronic lymphocytic leukemia
    不详
    FUTURE ONCOLOGY, 2010, 6 (01) : 10 - 10
  • [24] THE COURSE OF CORONAVIRUS DISEASE 2019 (COVID-19) IN PATIENTS WITH SJOGREN'S SYNDROME TREATED WITH ANTI-CD20 MONOCLONAL ANTIBODY (RITUXIMAB)
    Sokol, E.
    Torgashina, A.
    Chalcev, B.
    Khvan, J.
    Golovina, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 896 - 897
  • [25] What is the status of novel anti-CD20 antibodies for chronic lymphocytic leukemia and are they set to leave rituximab in the shadows?
    Chaudhry, Maria
    Cheson, Bruce D.
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (06) : 733 - 742
  • [26] Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy
    Eeva Feuth
    Valtteri Nieminen
    Antti Palomäki
    Juha Ranti
    Marcus Sucksdorff
    Taru Finnilä
    Jarmo Oksi
    Tytti Vuorinen
    Thijs Feuth
    European Journal of Clinical Microbiology & Infectious Diseases, 2024, 43 : 723 - 734
  • [27] Antibody-dependent cellular phagocytosis is responsible for efficacy of anti-CD20 monoclonal antibody therapy in chronic lymphocytic leukemia
    Chu, Charles C.
    VanDerMeid, Karl R.
    Elliott, Michael Rusty
    Baran, Andrea M.
    Barr, Paul M.
    Zent, Clive S.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [28] Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy
    Feuth, Eeva
    Nieminen, Valtteri
    Palomaeki, Antti
    Ranti, Juha
    Sucksdorff, Marcus
    Finnilae, Taru
    Oksi, Jarmo
    Vuorinen, Tytti
    Feuth, Thijs
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2024, 43 (04) : 723 - 734
  • [29] Patterns of hepatitis B reactivation and liver test abnormalities in patients with chronic lymphocytic leukemia (CLL) treated with idelalisib plus an anti-CD20 antibody.
    Zelenetz, Andrew David
    Mato, Anthony R.
    Robak, Tadeusz
    Jones, Jeffrey Alan
    Pagel, John M.
    Barrientos, Jacqueline Claudia
    Brown, Jennifer R.
    Montillo, Marco
    Kipps, Thomas J.
    Dubowy, Ronald
    Xing, Guan
    Li, Julia
    Hillmen, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [30] Severe side effects in patients with B-cell chronic lymphocytic leukemia (CLL) and lymphocytosis treated with the monoclonal anti-CD20 antibody rituximab.
    Winkler, U
    Jensen, M
    Manzke, O
    Tesch, H
    Bohlen, H
    Diehl, V
    Engert, A
    BLOOD, 1998, 92 (10) : 285B - 285B
12345